BRIEF published on 12/19/2025 at 07:35, 6 months 16 days ago Sensorion to Present at J.P. Morgan Healthcare Conference Biotechnology Gene Therapy J.P. Morgan Hearing Loss SENS-401
PRESS RELEASE published on 12/19/2025 at 07:30, 6 months 16 days ago Informations privilégiées / Autres communiqués Sensorion annonce sa participation à la 44ème conférence annuelle J.P. Morgan Healthcare Conference à San Francisco du 12 au 15 janvier 2026 pour présenter ses avancées en thérapies auditives Biotechnologie Conference J.P. Morgan Sensorion Thérapies Auditives
PRESS RELEASE published on 12/19/2025 at 07:30, 6 months 16 days ago Inside Information / Other news releases Sensorion to present at 44th Annual J.P. Morgan Healthcare Conference with focus on novel therapies for hearing loss disorders. CEO Nawal Ouzren to lead presentation Biotechnology Sensorion Hearing Loss Disorders J.P. Morgan Healthcare Conference Thérapies
BRIEF published on 09/17/2025 at 07:35, 9 months 17 days ago Sensorion announces its 2025 half-year results Funding Gene Therapy SENS-401 SENS-501 2025 Results
BRIEF published on 09/17/2025 at 07:35, 9 months 17 days ago Sensorion annonce ses résultats semestriels 2025 Financement Thérapie Génique SENS-401 SENS-501 Résultats 2025
PRESS RELEASE published on 09/17/2025 at 07:30, 9 months 17 days ago Inside Information / News release on accounts, results Sensorion reports 2025 half-year results, corporate update, and availability of half-year report. Progress in gene therapy programs for hearing loss disorders discussed Clinical Trials Gene Therapy Sensorion Hearing Loss Disorders 2025 Half-Year Results
PRESS RELEASE published on 09/17/2025 at 07:30, 9 months 17 days ago Informations privilégiées / Communiqué sur comptes, résultats Sensorion présente ses résultats du premier semestre 2025, activités de thérapie génique SENS-501, GJB2-GT et SENS-401, annonce dépôts réglementaires et études cliniques en cours Résultats Thérapie Génique Études Cliniques Dépôts Réglementaires Sensorion
BRIEF published on 09/04/2025 at 07:35, 10 months ago Sensorion présentera au 60e atelier sur la biologie de l'oreille interne Biotechnologie Thérapie Génique Sensorion Perte Auditive Atelier De Biologie De L'oreille Interne
BRIEF published on 09/04/2025 at 07:35, 10 months ago Sensorion to Present at 60th Inner Ear Biology Workshop Biotechnology Gene Therapy Sensorion Hearing Loss Inner Ear Biology Workshop
PRESS RELEASE published on 09/04/2025 at 07:30, 10 months ago Informations privilégiées / Autres communiqués Sensorion annonce sa participation à la 60ème conférence annuelle Inner Ear Biology Workshop pour présenter ses avancées en thérapie génique pour la perte auditive Thérapie Génique Sensorion Perte Auditive Biologie Oreille Interne 60ème Conférence
Published on 07/03/2026 at 23:00, 19 hours 13 minutes ago Eagle Plains Partner Refined Energy Announces Final Results for Winter 2026 Drill Program at Dufferin West
Published on 07/03/2026 at 21:28, 20 hours 45 minutes ago Trifecta Gold Announces Closing of $1.66 Million Private Placement
Published on 07/03/2026 at 19:30, 22 hours 43 minutes ago Polaris Renewable Energy Announces Q2 2026 Investor Call Details
Published on 07/03/2026 at 13:30, 1 day 4 hours ago Nextech3D.ai Unveils Strategic AI Growth Roadmap Focused on Workforce Intelligence and Event Technology Innovation
Published on 07/04/2026 at 17:35, 37 minutes ago Vantage Introduces 24/7 Gold CFD Trading with XAUUSD247
Published on 07/04/2026 at 11:01, 7 hours 11 minutes ago EQS-Adhoc: Continental AG: Continental AG Sells ContiTech Group Sector
Published on 07/04/2026 at 09:05, 9 hours 7 minutes ago Velo x McLaren Mastercard Formula 1® Team Relaunches Live Your Fandom to Bring Fans Closer to the Sport They Love
Published on 07/03/2026 at 19:00, 23 hours 13 minutes ago PATRIMOINE ET COMMERCE: BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE AU 30 JUIN 2026
Published on 07/03/2026 at 18:55, 23 hours 17 minutes ago Saudia Arabia's Mabani Aljazeera Group invests in Tatu City's Jabali Towers development
Published on 07/03/2026 at 21:49, 20 hours 23 minutes ago Safran annonce la fin des négociations concernant le projet d'acquisition d’Exail Technologies.
Published on 07/03/2026 at 21:49, 20 hours 23 minutes ago Safran announces the end of negotiations regarding the contemplated acquisition of Exail Technologies.
Published on 07/03/2026 at 18:42, 23 hours 30 minutes ago Total number of voting rights and shares making up the share capital at June 30, 2026
Published on 07/03/2026 at 18:36, 23 hours 36 minutes ago Disclosure of transactions in own shares from July 1 to July 3, 2026
